Sartorius Accessia Pharma
La probabilité de faillite calculée de Sartorius Accessia Pharma sur 12 mois est de 0,7% (faible). L'entreprise est active depuis 2016 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 10 ans |
| Sites | 1 |
| Publications | 14 |
Estimation statistique fondée sur des sources publiques, pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2025 | volledig | 13-04-2026 | 2026-00077882 |
| 31-12-2024 | volledig | 09-04-2025 | 2025-00068326 |
| 31-12-2023 | volledig | 29-05-2024 | 2024-00099693 |
| 31-12-2022 | volledig | 26-05-2023 | 2023-00095228 |
| 31-12-2021 | volledig | 10-08-2022 | 2022-20283644 |
| 31-12-2020 | volledig | 12-04-2021 | 2021-10200452 |
| 31-12-2019 | volledig | 24-06-2020 | 2020-20900112 |
| 31-12-2018 | volledig | 19-03-2019 | 2019-07600595 |
| 31-12-2017 | volledig | 25-04-2018 | 2018-10700436 |
| NACE primaire | Activités de location(77399) |
| Forme juridique | SA(014) |
| Date de constitution | 22-03-2016 |
| Status | Actif |
| Code postal | 4041 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 62064A0220/00G000 | Wallonie | 8 511 m² | 1 · 1 406 m² | 12,8 m · 3 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
28-01-2025 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Sartorius Accessia Pharma",
"old": "ACCESSIA PHARMA",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}25-04-2024 3 administrateurs nommés, 2 démissionnaires
- Jonas Skjødt MOLLER, Bestuurder
- Franck BACKERS, Bestuurder
- Franck BACKERS, Gedelegeerd bestuurder
- MPH SRL, Gedelegeerd bestuurder
- MDT Services & Technologies SRL, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jonas Skj\u00F8dt MOLLER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MPH SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}11-04-2023 4 administrateurs nommés
- MDT SERVICES & TECHNOLOGIES, Bestuurder
- MPH, Bestuurder
- MDT SERVICES & TECHNOLOGIES, Gedelegeerd bestuurder
- MPH, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MPH",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MPH",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-12-2022 2 administrateurs nommés, 4 démissionnaires
- MPH SRL, Bestuurder
- MDT Services & Technologies, Personne déléguée à la gestion journalière
- Xpress Biologics SA, Bestuurder
- MDT Services & Technologies, Bestuurder
- Xpress Biologics SA, Personne déléguée à la gestion journalière
- MDT Services & Technologies, Personne déléguée à la gestion journalière
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Xpress Biologics SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MPH SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Xpress Biologics SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "MDT Services \u0026 Technologies",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-09-2022 1 administrateur nommé, 1 démissionnaire
- Mazars Réviseurs d'Entreprises SRL, Auditor
- Deloitte Bedrijfsreviscren/Réviseurs d'Entreprises BV/SRL, Auditor
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "auditor",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsreviscren/R\u00E9viseurs d\u0027Entreprises BV/SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Mazars R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}27-07-2022 5 administrateurs nommés, 6 démissionnaires
- MDT SERVICES & TECHNOLOGIES, Bestuurder
- XPRESS BIOLOGICS, Bestuurder
- MDT SERVICES & TECHNOLOGIES, Gedelegeerd bestuurder
- XPRESS BIOLOGICS, Gedelegeerd bestuurder
- Franck BACKERS, Cfo
- SMAL Jean, Bestuurder
- SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, Bestuurder
- NOSHAQ, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SMAL Jean",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "NOSHAQ",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monument Immo Management",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SAMANDA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "XPRESS BIOLOGICS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Leap Consulting",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "MDT SERVICES \u0026 TECHNOLOGIES",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "XPRESS BIOLOGICS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "CFO",
"person": {
"rrn": null,
"name": "Franck BACKERS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}19-07-2022 3 administrateurs nommés, 2 démissionnaires
- Marie Braun, Bestuurder
- Leap Consulting SPRL, Dagelijks bestuur
- Benjamin Boinem, Dagelijks bestuur
- Marc Foidart, Bestuurder
- Mr. Verjans, Dagelijks bestuur
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Marie Braun",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Marc Foidart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Leap Consulting SPRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Benjamin Boinem",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "D\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Mr. Verjans",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}11-05-2022 Réduction de capital de 2.600.000 € à 7.400.000 €
- €10.000.000 → €7.400.000
Détails techniques
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 7400000,
"delta_eur": -2600000,
"before_eur": 10000000,
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}30-04-2021 Julie Delforge nommé commissaire aux comptes
- Julie Delforge, Commissaire aux comptes
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaire aux comptes",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}03-11-2020 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}25-02-2019 1 administrateur nommé, 1 démissionnaire
- FRANSSEN Christina, Representant permanent
- BASTIN David, Representant permanent
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "representant permanent",
"person": {
"rrn": null,
"name": "FRANSSEN Christina",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "representant permanent",
"person": {
"rrn": null,
"name": "BASTIN David",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA PHARMA"
}
}22-03-2017 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "ACCESSIA PHARMA",
"old": "ACCESSIA GMP",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA GMP"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}14-11-2016 Augmentation de capital de 1.000.000 € à 4.000.000 €
- €3.000.000 → €4.000.000
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 4000000,
"delta_eur": 1000000,
"before_eur": 3000000,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0650.670.852",
"name_full": "ACCESSIA GMP"
}
}24-03-2016 Constitution d'une société (SA)
Détails techniques
{
"notary": {
"name": "Jean-Michel Gauthy",
"firm_city": null,
"firm_name": "Gauthy \u0026 Jacques \u2013 Notaires Associ\u00E9s",
"office_city": "Li\u00E8ge",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2016-03-24",
"filing_date": "2016-03-22",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-03-22",
"unanimous": true
},
"founders": [
{
"org": {
"kbo": "0877.938.090",
"name": "SOFIP\u00D4LE SA",
"address": "4000 Li\u00E8ge, avenue Maurice Destenay, 13",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0474.379.686",
"name": "INTEGRALE IMMO MANAGEMENT SA",
"address": "4000 Li\u00E8ge, Place Saint-Jacques, 11, bo\u00EEte 103",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0426.624.509",
"name": "SOCI\u00C9T\u00C9 DE D\u00C9VELOPPEMENT ET DE PARTICIPATION DU BASSIN DE LI\u00C8GE",
"address": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3",
"country": "BE",
"legal_form": "SA",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 1000000.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet principal de construire, installer, \u00E9quiper, valider, faire approuver par les autorit\u00E9s comp\u00E9tentes, g\u00E9rer et maintenir des sites de R\u0026D et de production GMP pour des soci\u00E9t\u00E9s actives dans le secteur de la sant\u00E9 (pharmaceutique, biotechnologique, medical device, diagnostique et autres activit\u00E9s similaires). La soci\u00E9t\u00E9 offrira des salles blanches, des laboratoires, des bureaux, des zones de stockage dans diff\u00E9rentes conditions et toute autre structure qui pourrait \u00EAtre utile dans le cadre de son activit\u00E9 et de l\u2019activit\u00E9 de ses clients. La soci\u00E9t\u00E9 sera \u00E9galement active dans l\u2019offre de services autour de son activit\u00E9 principale, ce qui comprend mais n\u2019est pas limit\u00E9 \u00E0 : un support en terme de qualit\u00E9 (contr\u00F4le de qualit\u00E9 et assurance de qualit\u00E9), l\u2019achat et l\u2019installation d\u2019\u00E9quipements de production et de recherche, l\u2019offre de service de maintenance d\u2019\u00E9quipement de production, la mise \u00E0 disposition de personnel de production, la lib\u00E9ration de lots de production.\n\nElle peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet.\n\nLa soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par toutes voies dans toutes affaires, entreprises ou soci\u00E9t\u00E9s ayant un objet identique, similaire ou connexe, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u0027\u00E9coulement de ses produits.",
"is_lucrative": true,
"short_summary": "Construction, installation, equipment, management, and maintenance of GMP R\u0026D and production sites for health sector companies, including clean rooms, laboratories, offices, storage areas, and related services."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": 5,
"n_directors_min": 1,
"representation_clause": "twee bestuurders",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2017-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "10:00",
"month": 3,
"rule_text": "deuxi\u00E8me vendredi du mois de mars"
},
"founding_event": {
"n_shares_total": 3000,
"n_share_classes": 1,
"bank_attestation": {
"date": "2016-03-22",
"bank_name": "KBC",
"amount_eur": 3000000.0,
"iban_masked": "BE43 3632 6778 4001"
},
"amount_paid_in_eur": 3000000.0,
"incorporation_date": "2016-03-22",
"amount_subscribed_eur": 3000000.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": "2015-11-01"
},
"subject_company": {
"kbo": "0650.670.852",
"email": null,
"region": "waals_gewest",
"website": null,
"name_full": "ACCESSIA GMP",
"legal_form": "SA",
"name_abbreviated": "ACCESSIA GMP",
"zetel_address_raw": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3",
"equity_account_type": "available",
"_kbo_extracted_mismatch": "0877.938.090"
},
"initial_directors": [
{
"kind": "rechtspersoon",
"person": {
"name": "SAMANDA",
"address": "4000 Li\u00E8ge, avenue Maurice Destenay, 13"
},
"via_org": {
"kbo": "0877.938.090",
"name": "SOFIP\u00D4LE SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "David Bastin",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "rechtspersoon",
"person": {
"name": "INTEGRALE IMMO MANAGEMENT SA",
"address": "4000 Li\u00E8ge, Place Saint-Jacques, 11, bo\u00EEte 103"
},
"via_org": {
"kbo": "0474.379.686",
"name": "INTEGRALE IMMO MANAGEMENT SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "C\u00E9dric Sacr\u00E9",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "rechtspersoon",
"person": {
"name": "MEUSINVEST SA",
"address": "4000 Li\u00E8ge, H\u00F4tel de Copis, rue Lambert Lombard 3"
},
"via_org": {
"kbo": "0426.624.509",
"name": "MEUSINVEST SA",
"legal_form": "SA"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": "Marc Foidart",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2016-03-22",
"numac_or_number": "16029444"
}
},
{
"kind": "natural_person",
"person": {
"name": "Jean Smal",
"address": "1030 Bruxelles, avenue de l\u2019Opale, 106"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "until_agm_year",
"value": 2022
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "Beno\u00EEt Verjans",
"address": "1050 Bruxelles, rue de la Natation 30M"
},
"via_org": null,
"role_sub": "directeur_general",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"volmacht",
"plan financier",
"bankattest"
],
"post_incorporation_mandates": [
{
"kind": "volmacht_kbo",
"holder_org_kbo": "0877.938.090",
"holder_org_name": "Gauthy \u0026 Jacques \u2013 Notaires Associ\u00E9s",
"with_substitution": false,
"holder_person_name": null
}
]
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | Sartorius Accessia Pharma |